Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON24304
NL-OMON24304
Not yet recruiting
Not Applicable

Esophagectomy for patients with resectable esophageal cancer and cervical lymph node metastases

niversity Medical Center Utrecht0 sites20 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsEsophageal cancerCervical lymph node metastasis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Esophageal cancer
Sponsor
niversity Medical Center Utrecht
Enrollment
20
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Histologically proven squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus.
  • •\-Surgical resectable carcinoma (T1\-4a, N0\-3\)

Exclusion Criteria

  • •\- Distant metastases
  • •\- Inadequate pulmonary function disabling transthoracic resection

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
ode study: 'Esophageal resection for patients with esophageal cancer and cervical lymph node metastases'esophageal cancer with cervical lymphnode metastasis100179901001799110017998
NL-OMON44167Heelkunde, chirurgie20
Active, not recruiting
Not Applicable
Healing of patients suffering from gastroesophageal reflux esophagitisgrade C-D according to Los Angeles classification after treatment with pantoprazole-magnesium dihydrate 80 mg o.d. in comparison topantoprazole-sodium sesquihydrate 40 mg o.d. over 4 or 8 weeks - Magnum IIGastroesophageal reflux esophagitisMedDRA version: 5.0Level: lltClassification code 10038263
EUCTR2004-000492-33-LTALTANA Pharma AG800
Active, not recruiting
Not Applicable
Healing of patients suffering from gastroesophageal reflux esophagitisgrade C-D according to Los Angeles classification after treatment with pantoprazole-magnesium dihydrate 80 mg o.d. in comparison topantoprazole-sodium sesquihydrate 40 mg o.d. over 4 or 8 weeks
EUCTR2004-000492-33-LVALTANA Pharma AG800
Active, not recruiting
Not Applicable
Healing of patients suffering from gastroesophageal reflux esophagitisgrade A-D according to Los Angeles classification after treatment with pantoprazole-magnesium dihydrate 80 mg o.d. in comparison topantoprazole-sodium sesquihydrate 40 mg o.d. over 4 or 8 weeksGastroesophageal reflux esophagitisMedDRA version: 5.0Level: lltClassification code 10038263
EUCTR2004-000493-32-ATALTANA Pharma AG1,980
Active, not recruiting
Not Applicable
Healing of patients suffering from gastroesophageal reflux esophagitisgrade C-D according to Los Angeles classification after treatment with pantoprazole-magnesium dihydrate 80 mg o.d. in comparison topantoprazole-sodium sesquihydrate 40 mg o.d. over 4 or 8 weeks - Magnum II
EUCTR2004-000492-33-HUALTANA Pharma AG800